The Africa Centre Disease Control (CDC), with global health partners, has announced the launch of a "pivotal" clinical trial ...

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and ...

The Access and Allocation Mechanism (AAM) for mpox, a mechanism formed to counter mpox, has allocated an initial 899,000 ...

An initial 899,000 vaccine doses have been allocated to Nigeria and 8 other countries across Africa that have been hit ...

Pregnant women and infants are at risk should they contract mpox but there are no approved vaccines for this population.

“The supply includes contributions from multiple nations and organisations, including 1.85 million doses of MVA-BN from the ...

The WHO has declared a global health emergency over a new strain of mpox rapidly spreading in Africa. Here’s what you need to ...

How worried should the UK public be about the new case of mpox identified in the UK? Health Correspondent Rebecca Thomas ...

The registrational trial is expected to support the Bavarian’s mpox/smallpox vaccine use in children between 2 and 11 years ...

Results from this study could support an extension of the current approval of MVA-BN to include children from 2 years of age ...

Credit: Getty Images Researchers examined the safety and immunogenicity of 2 doses of MVA-BN vaccine administered subcutaneously 28 days apart in adolescents aged 12 to 17 years compared to adults.

HealthDay News — The Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine, licensed in the United States to prevent smallpox and mpox, is well tolerated and seems effective in adolescents, ...